Wilmington Funds Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.38M |
| 2 |
AGN
Allergan Inc
AGN
|
+$5.74M |
| 3 |
Oceaneering
OII
|
+$4.45M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$3.94M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$5.03M |
| 2 |
ExxonMobil
XOM
|
+$4.42M |
| 3 |
GE Aerospace
GE
|
+$3.28M |
| 4 |
Chevron
CVX
|
+$2.84M |
| 5 |
Herbalife
HLF
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.33% |
| 2 | Consumer Discretionary | 12.29% |
| 3 | Healthcare | 11.76% |
| 4 | Technology | 11.66% |
| 5 | Real Estate | 9.82% |
Similar funds
Wilmington Funds Management's Q2 2014 Portfolio in Review
As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.
- Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
- Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
- Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
- Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
- Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
- Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
- Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.
Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.